Alertas Bibliograficas – Pediatría

Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline
Eystein S Husebye, Frederik Castinetti, et al. 
Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21. 
https://doi.org/10.1530/EJE-22-0689

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret C S Boguszewski, Cesar L Boguszewski , et al. 
Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. 
https://doi.org/10.1530/EJE-21-1186

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
John P Bilezikian 1, Aliya A Khan, et al. 
J Bone Miner Res. 2022 Nov;37(11):2293-2314. 
https://doi.org/10.1002/jbmr.4677

Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Antonio Marcondes Lerario, Dipika R Mohan, Gary D Hammer, et al.  
Endocr Rev. 2022 Nov 25;43(6):1051-1073.
https://doi.org/10.1210/endrev/bnac012

Management of thyroid eye disease: a Consensus Statement by the American Thyroid  Association and the European Thyroid Association. 
Burch, H. B., Perros, P.,  et al.  
Eur Thyroid J. 2022 Dec 1; 11(6): e220189.
https://doi.org/10.1530/ETJ-22-0189

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. 
Coleman, E., Radix, A. E. et al. 
International journal of transgender health, 23(Suppl 1), S1–S259. 
https://doi.org/10.1080/26895269.2022.2100644

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline
Ghada El-Hajj Fuleihan, Gregory A Clines, et al.
J Clin Endocrinol Metab. 2023 Feb 15;108(3):507-528. doi: 10.1210/clinem/dgac621.
DOI: 10.1210/clinem/dgac621

Diagnosis and Management of Central Diabetes Insipidus in Adults
Maria Tomkins, Sarah Lawless, et al.
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2701-2715. 
doi: 10.1210/clinem/dgac381